Perspective Therapeutics (CATX) Construction in Progress (2011)
Perspective Therapeutics recorded quarterly Construction in Progress of $123613.0 in Q2 2011.
Perspective Therapeutics' Construction in Progress history runs 1 years deep, the most recent figure standing at $123613.0 for Q2 2011.
- In Q2 2011, Construction in Progress changed N/A year-over-year to $123613.0; the TTM figure through Jun 2011 stood at $123613.0 (changed N/A YoY), while the FY2011 annual figure was $123613.0, changed N/A from the prior year.
- Construction in Progress came in at $123613.0 for Q2 2011 at Perspective Therapeutics.
- In the past five years, Construction in Progress ranged from a high of $123613.0 in Q2 2011 to a low of $123613.0 in Q2 2011.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.12 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 509.50 Mn |
| 10 | Perspective Therapeutics | 380.23 Mn | 380.23 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2011 | 123,613.00 |